Matt Stoll

Title: Matt Stoll: Innovator in Cerebrospinal Fluid Treatment

Introduction: Matt Stoll is an accomplished inventor based in Minneapolis, MN, known for his significant contribution to the medical field through his innovative patent. With one patent to his name, Stoll is making strides in the treatment of biologic fluids, particularly cerebrospinal fluid (CSF).

Latest Patents: Stoll's patent, titled "Systems and methods for the conditioning of cerebrospinal fluid," outlines groundbreaking methods for treating biologic fluids. The invention includes techniques for filtering CSF from human or animal subjects, controlling its temperature, applying light treatment, separating cells using their dielectric properties, and integrating additives. The method emphasizes a comprehensive approach where fluid is withdrawn, treated, and then returned to the subject, allowing easy modification of parameters like flow rate during its operation.

Career Highlights: Currently, Matt Stoll is employed at Minnetronix, Inc., where he leverages his expertise to develop advanced medical technologies. His patent signifies his commitment to improving health outcomes and showcases his innovative thinking in the biomedical realm.

Collaborations: Stoll's work involves collaboration with esteemed colleagues, including Blake A. Hedstrom and Shivanand Lad, who contribute to the innovative environment at Minnetronix. Their collective efforts in research and development continue to push the boundaries of medical fluid treatment.

Conclusion: Matt Stoll is a notable inventor whose dedication to innovation in treating cerebrospinal fluid is paving the way for advancements in medical practices. Through his patent and collaboration with talented individuals, Stoll signifies the impact that focused research and creative applications can have on healthcare.